ChongKunDang to join W1tr club

ChongKunDang Pharmaceutical will post record earnings in the fourth quarter and join the1 trillion won (US$891.19 million) league,” said Cape Investment and Securities on Nov. 30 maintaining a “buy” recommendation. The securities firm, however, lowered the target price to 150,000 won from 180,000 won reflecting discount on top pharmaceutical companies’ profit targets.

Asian stocks buoyed by dovish Fed, declining Treasury yields boost equities

Asian equities are largely on the bullish side after the US Federal Reserve’s chairman, Jerome Powell, reversed the US central bank’s previously-hawkish policy, suggesting that current rates are much closer to normal than his previous showings, wordlessly suggesting to broader markets that the Fed may ease off their current path of rate hikes much sooner than previously expected.

error: Content is protected !!